Anthropic sets up biology lab with Claude-guided robots for drug experiments

anthropic is establishing a biology lab in the san francisco area where its ai model claude will guide robots through drug experiments with minimal human involvement. the lab will enable the company to run physical experiments, building on its earlier efforts in ai-driven drug development. anthropic has developed two tools to support this work: claude science, an ai workspace for researchers, and the model hardware standard for controlling lab equipment. human oversight will still be required for safety. the company sees opportunities in diseases considered 'undruggable' and aims to speed up the design of complex antibodies. this move follows anthropic's acquisition of coefficient bio for $400 million and the addition of novartis ceo vas narasimhan to its board.